RAMMURTI KAMBLE

Concepts (412)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
110
2024
1203
10.210
Why?
Graft vs Host Disease
40
2024
543
4.270
Why?
Transplantation Conditioning
46
2022
325
3.900
Why?
Multiple Myeloma
23
2022
161
3.130
Why?
Transplantation, Homologous
45
2024
667
2.420
Why?
Leukemia, Myeloid, Acute
19
2021
536
2.060
Why?
Transplantation, Autologous
28
2022
300
2.000
Why?
Myelodysplastic Syndromes
14
2022
138
1.840
Why?
Bone Marrow Transplantation
12
2020
575
1.450
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
2022
783
1.230
Why?
Unrelated Donors
15
2022
82
1.160
Why?
Amyloidosis
5
2020
71
0.950
Why?
Middle Aged
91
2024
26927
0.950
Why?
Myeloablative Agonists
10
2020
25
0.940
Why?
Adult
98
2024
29628
0.930
Why?
Leukemia
7
2022
372
0.900
Why?
Granulocyte Colony-Stimulating Factor
6
2020
96
0.880
Why?
Hematologic Neoplasms
9
2021
285
0.870
Why?
Antineoplastic Combined Chemotherapy Protocols
15
2022
1251
0.810
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
5
2016
183
0.800
Why?
Disease-Free Survival
28
2022
897
0.780
Why?
Aged
64
2024
19870
0.760
Why?
Lymphoma, Large B-Cell, Diffuse
6
2020
144
0.750
Why?
Humans
158
2024
125189
0.740
Why?
Male
104
2024
61525
0.730
Why?
Neoplasms, Second Primary
8
2017
152
0.680
Why?
Lymphoma, Follicular
4
2017
30
0.640
Why?
Roseolovirus Infections
3
2011
33
0.640
Why?
Herpesvirus 6, Human
3
2011
58
0.630
Why?
Female
96
2024
66806
0.620
Why?
Photosensitivity Disorders
1
2018
11
0.610
Why?
Immunosuppressive Agents
6
2020
651
0.600
Why?
Voriconazole
1
2018
35
0.600
Why?
Peripheral Blood Stem Cell Transplantation
6
2019
38
0.600
Why?
Lymphoproliferative Disorders
2
2019
225
0.600
Why?
Siblings
12
2022
196
0.590
Why?
Allografts
17
2021
191
0.570
Why?
Tissue Donors
11
2021
494
0.560
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
2020
97
0.560
Why?
T-Lymphocytes
9
2024
1726
0.550
Why?
Young Adult
39
2024
9053
0.530
Why?
Stem Cell Transplantation
5
2022
237
0.530
Why?
Salvage Therapy
6
2021
192
0.530
Why?
Survival Analysis
21
2021
1506
0.520
Why?
Antibodies, Monoclonal
4
2020
1033
0.520
Why?
Epstein-Barr Virus Infections
1
2019
294
0.520
Why?
Lymphoma
5
2021
323
0.520
Why?
Iron Overload
2
2006
16
0.520
Why?
Treatment Outcome
41
2021
12392
0.510
Why?
Adolescent
48
2024
19363
0.510
Why?
Hematopoietic Stem Cell Mobilization
5
2020
30
0.510
Why?
Recurrence
20
2022
1420
0.510
Why?
Clinical Trials as Topic
1
2020
1099
0.490
Why?
Melphalan
8
2022
49
0.480
Why?
Lymphoma, Non-Hodgkin
5
2020
164
0.480
Why?
Heart Transplantation
3
2020
862
0.450
Why?
Skin Ulcer
1
2014
33
0.440
Why?
Thalidomide
1
2014
36
0.440
Why?
Leukemia, Myeloid
4
2017
85
0.440
Why?
Primary Myelofibrosis
3
2023
51
0.430
Why?
Encephalitis, Varicella Zoster
1
2013
2
0.430
Why?
Leukemoid Reaction
1
2013
3
0.430
Why?
Meningoencephalitis
1
2013
18
0.420
Why?
Anemia, Aplastic
3
2020
59
0.420
Why?
Cytomegalovirus Infections
3
2024
221
0.410
Why?
Retrospective Studies
30
2024
16353
0.400
Why?
Incidence
9
2024
3147
0.400
Why?
Survival Rate
17
2021
2062
0.400
Why?
Antineoplastic Agents
3
2022
1691
0.400
Why?
Cardiomyopathies
2
2019
499
0.390
Why?
Azoles
1
2012
9
0.390
Why?
Cushing Syndrome
1
2012
16
0.390
Why?
Budesonide
1
2012
19
0.390
Why?
Cyclosporine
2
2019
147
0.380
Why?
Bone Marrow
3
2021
325
0.370
Why?
HLA Antigens
7
2019
245
0.360
Why?
Bone Marrow Cells
3
2021
264
0.350
Why?
Rituximab
6
2022
159
0.340
Why?
Graft vs Leukemia Effect
2
2021
30
0.340
Why?
Prognosis
19
2021
4645
0.330
Why?
Hodgkin Disease
3
2022
292
0.330
Why?
Child, Preschool
22
2024
14027
0.320
Why?
Anti-Inflammatory Agents
1
2012
293
0.320
Why?
Mycophenolic Acid
2
2019
51
0.310
Why?
Graft Survival
4
2012
538
0.310
Why?
Gout
1
2011
148
0.300
Why?
Plasma Cells
2
2020
54
0.290
Why?
Alemtuzumab
2
2024
88
0.290
Why?
Graft Rejection
2
2017
590
0.290
Why?
Cytokines
2
2011
1288
0.290
Why?
Antigens, CD19
4
2018
177
0.290
Why?
Child
30
2024
24421
0.290
Why?
Eye Diseases
2
2019
119
0.280
Why?
Paramyxoviridae Infections
1
2007
47
0.270
Why?
Antibodies, Neoplasm
1
2007
60
0.270
Why?
Encephalitis, Viral
1
2007
21
0.270
Why?
Metapneumovirus
1
2007
51
0.270
Why?
Paresis
1
2006
35
0.270
Why?
Infant
18
2024
12516
0.270
Why?
Combined Modality Therapy
9
2021
1242
0.270
Why?
Hemoglobin SC Disease
1
2006
12
0.260
Why?
Lymphoma, T-Cell
1
2006
64
0.260
Why?
Erythrocyte Indices
1
2006
15
0.250
Why?
Histocompatibility Testing
5
2021
148
0.250
Why?
Receptors, Antigen, T-Cell
3
2020
482
0.250
Why?
Quality of Life
5
2023
1934
0.250
Why?
Survivors
4
2019
339
0.250
Why?
beta 2-Microglobulin
1
2005
35
0.250
Why?
Pleural Effusion, Malignant
1
2005
14
0.240
Why?
Remission Induction
9
2021
300
0.240
Why?
Cyclophosphamide
6
2022
417
0.240
Why?
Acute Disease
8
2019
1111
0.240
Why?
L-Lactate Dehydrogenase
1
2005
62
0.240
Why?
Burkitt Lymphoma
1
2006
144
0.240
Why?
Erythrocyte Transfusion
1
2006
130
0.230
Why?
Antiviral Agents
3
2024
753
0.230
Why?
Maintenance Chemotherapy
2
2022
20
0.230
Why?
Whole-Body Irradiation
5
2020
64
0.230
Why?
Busulfan
4
2020
45
0.230
Why?
Cord Blood Stem Cell Transplantation
2
2017
48
0.230
Why?
Neutropenia
1
2006
200
0.220
Why?
Antigens, Neoplasm
3
2021
385
0.220
Why?
Lymphocyte Transfusion
2
2021
57
0.220
Why?
Vancomycin
1
2006
220
0.220
Why?
Quinazolines
1
2024
175
0.210
Why?
Janus Kinase Inhibitors
1
2023
22
0.210
Why?
Hematopoietic Stem Cells
2
2020
541
0.210
Why?
Lung Neoplasms
3
2006
1659
0.200
Why?
Metabolic Syndrome
2
2016
343
0.200
Why?
C-Reactive Protein
1
2005
432
0.200
Why?
Cell- and Tissue-Based Therapy
2
2021
164
0.200
Why?
Follow-Up Studies
10
2021
5176
0.200
Why?
Bacterial Infections
1
2005
308
0.200
Why?
Leukemia, Prolymphocytic, T-Cell
1
2022
2
0.190
Why?
Liver Diseases
1
2006
367
0.190
Why?
Neoplasm Recurrence, Local
7
2022
1140
0.190
Why?
Risk Factors
14
2024
10315
0.190
Why?
Diagnosis, Differential
3
2006
1897
0.190
Why?
Seizures
1
2006
872
0.180
Why?
Disease Progression
8
2022
2067
0.180
Why?
Community Health Planning
1
2020
9
0.180
Why?
Body Mass Index
5
2020
1565
0.170
Why?
Time-to-Treatment
2
2019
188
0.170
Why?
Peripheral Blood Stem Cells
1
2020
3
0.170
Why?
Blood Transfusion, Autologous
1
2020
34
0.170
Why?
Health Information Systems
1
2020
32
0.160
Why?
Virus Integration
2
2011
42
0.160
Why?
Chronic Disease
7
2021
1197
0.160
Why?
United States Food and Drug Administration
1
2020
150
0.160
Why?
United States
9
2021
10915
0.160
Why?
Tissue and Organ Harvesting
2
2020
40
0.160
Why?
Social Determinants of Health
1
2021
126
0.160
Why?
Protein Kinase Inhibitors
3
2020
541
0.150
Why?
Foot Diseases
1
1998
24
0.150
Why?
Herpesvirus 4, Human
2
2019
676
0.150
Why?
Cohort Studies
9
2022
4817
0.150
Why?
Translocation, Genetic
1
2020
358
0.150
Why?
Calcineurin Inhibitors
1
2018
29
0.150
Why?
Neoplasms, Germ Cell and Embryonal
1
2019
87
0.150
Why?
Practice Patterns, Physicians'
2
2015
731
0.150
Why?
Minority Groups
1
2020
249
0.150
Why?
Lymphoma, T-Cell, Peripheral
1
2018
14
0.150
Why?
Multivariate Analysis
6
2020
1438
0.150
Why?
Registries
3
2020
1435
0.150
Why?
Tacrolimus
1
2018
98
0.150
Why?
Skin Neoplasms
2
2015
862
0.150
Why?
Testicular Neoplasms
1
2019
132
0.140
Why?
Donor Selection
1
2018
55
0.140
Why?
Leukemic Infiltration
1
1997
9
0.140
Why?
Poverty
1
2021
425
0.140
Why?
Viral Load
1
2019
387
0.140
Why?
Neoplasms
3
2021
2790
0.140
Why?
Antigens, CD34
3
2020
109
0.140
Why?
Osteonecrosis
2
2014
11
0.140
Why?
Aged, 80 and over
9
2020
6598
0.140
Why?
Cervix Uteri
1
1997
64
0.140
Why?
Neoplasm Staging
4
2018
1275
0.130
Why?
Recombinant Proteins
4
2014
1399
0.130
Why?
Activities of Daily Living
1
2019
405
0.130
Why?
CD8-Positive T-Lymphocytes
1
2019
397
0.130
Why?
fms-Like Tyrosine Kinase 3
1
2016
23
0.130
Why?
Immunoglobulin kappa-Chains
1
2016
30
0.130
Why?
Methotrexate
1
2018
334
0.130
Why?
CD4-Positive T-Lymphocytes
1
2019
472
0.130
Why?
Hospitals, Special
1
2015
13
0.130
Why?
Janus Kinase 1
1
2015
12
0.130
Why?
Filgrastim
3
2015
15
0.130
Why?
Antifungal Agents
1
2018
291
0.130
Why?
Databases, Factual
5
2021
1179
0.120
Why?
Biopsy
2
2012
1238
0.120
Why?
Ferritins
2
2006
98
0.120
Why?
Cytomegalovirus
3
2024
270
0.120
Why?
DNA, Viral
2
2007
480
0.120
Why?
Immunoglobulin Light Chains
1
2015
26
0.120
Why?
Proportional Hazards Models
5
2020
1360
0.120
Why?
Sarcoma, Myeloid
1
2015
12
0.120
Why?
Hospitals, Low-Volume
1
2015
31
0.120
Why?
Hospitals, High-Volume
1
2015
36
0.120
Why?
Antineoplastic Agents, Alkylating
1
2015
100
0.120
Why?
Caspase 9
1
2015
75
0.120
Why?
Blood Donors
3
2020
62
0.120
Why?
Treatment Failure
4
2020
341
0.120
Why?
Antibodies, Monoclonal, Murine-Derived
3
2014
63
0.110
Why?
Central Nervous System Neoplasms
1
2017
197
0.110
Why?
Janus Kinase 2
1
2015
132
0.110
Why?
Prospective Studies
5
2020
6153
0.110
Why?
Anti-Bacterial Agents
1
2006
2431
0.110
Why?
Bortezomib
3
2022
70
0.110
Why?
Social Class
1
2015
190
0.110
Why?
Waldenstrom Macroglobulinemia
1
2016
121
0.110
Why?
Cardiovascular Diseases
2
2016
1970
0.110
Why?
Administration, Oral
2
2014
684
0.110
Why?
Anemia, Sickle Cell
1
2017
330
0.110
Why?
Time Factors
6
2019
6338
0.110
Why?
Depressive Disorder
1
2017
454
0.110
Why?
Meningeal Neoplasms
1
2015
185
0.100
Why?
Mass Screening
2
2018
784
0.100
Why?
Models, Theoretical
1
2015
363
0.100
Why?
Patient Acceptance of Health Care
1
2017
425
0.100
Why?
Guideline Adherence
1
2015
378
0.100
Why?
Lymphoma, Mantle-Cell
1
2013
28
0.100
Why?
Fetal Blood
2
2022
176
0.100
Why?
Dexamethasone
2
2022
276
0.100
Why?
Fertility Preservation
1
2013
52
0.100
Why?
Parathyroid Hormone
1
2012
71
0.100
Why?
Immunotherapy, Adoptive
1
2018
832
0.100
Why?
Age Factors
5
2017
2823
0.090
Why?
Bone and Bones
1
2014
267
0.090
Why?
Colchicine
1
2011
44
0.090
Why?
Hematologic Diseases
1
2012
79
0.090
Why?
Cause of Death
3
2021
476
0.090
Why?
Chromosomes, Human
1
2011
128
0.090
Why?
Autografts
3
2015
26
0.090
Why?
Carmustine
2
2022
26
0.090
Why?
Iatrogenic Disease
1
2012
133
0.090
Why?
Drug Interactions
1
2012
257
0.090
Why?
CD28 Antigens
1
2011
81
0.090
Why?
Cytarabine
2
2022
97
0.090
Why?
Allopurinol
1
2011
71
0.090
Why?
B-Lymphocytes
1
2013
534
0.090
Why?
Steroids
1
2011
203
0.090
Why?
Kaplan-Meier Estimate
4
2016
1056
0.090
Why?
Etoposide
3
2020
115
0.080
Why?
Arsenicals
1
2009
14
0.080
Why?
Lymphoma, B-Cell
1
2011
141
0.080
Why?
Oxides
1
2009
15
0.080
Why?
Boronic Acids
1
2009
46
0.080
Why?
Pyrazines
1
2009
73
0.080
Why?
p38 Mitogen-Activated Protein Kinases
1
2009
130
0.080
Why?
Karyotyping
2
2006
323
0.070
Why?
Depression
1
2017
1237
0.070
Why?
Gastrointestinal Diseases
1
2012
339
0.070
Why?
Severity of Illness Index
4
2019
2913
0.070
Why?
Sex Factors
3
2018
1289
0.070
Why?
Chromosome Aberrations
2
2021
613
0.070
Why?
Vidarabine
2
2020
79
0.070
Why?
Cerebrospinal Fluid Proteins
1
2007
23
0.070
Why?
Heart Failure
1
2020
2298
0.070
Why?
Myocardium
1
2012
1020
0.070
Why?
Mutation
2
2020
5845
0.070
Why?
Vincristine
2
2006
193
0.070
Why?
Exchange Transfusion, Whole Blood
1
2006
14
0.070
Why?
Health Knowledge, Attitudes, Practice
1
2013
854
0.070
Why?
Clinical Decision-Making
2
2019
264
0.070
Why?
Epoetin Alfa
1
2006
10
0.070
Why?
Cell Count
2
2019
254
0.070
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2006
63
0.070
Why?
Darbepoetin alfa
1
2006
15
0.070
Why?
Hematopoietic System
1
2006
7
0.070
Why?
Phlebotomy
1
2006
16
0.060
Why?
Drug Resistance
2
2018
257
0.060
Why?
Bronchoalveolar Lavage
1
2006
23
0.060
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2006
41
0.060
Why?
Transferrin
1
2006
50
0.060
Why?
Doxorubicin
2
2006
290
0.060
Why?
Leukemia, Promyelocytic, Acute
1
2006
24
0.060
Why?
Pancreatic Diseases
1
2006
38
0.060
Why?
Pituitary Gland, Posterior
1
2005
6
0.060
Why?
Bone Marrow Diseases
1
2006
41
0.060
Why?
Erythropoietin
1
2006
105
0.060
Why?
Tumor Burden
1
2006
230
0.060
Why?
Antigens, CD
1
2007
432
0.060
Why?
Ciprofloxacin
1
2005
66
0.060
Why?
Skin Diseases
1
2006
130
0.060
Why?
Specimen Handling
1
2005
142
0.060
Why?
Pituitary Neoplasms
1
2005
80
0.060
Why?
Acetates
1
2024
74
0.060
Why?
Lymphocyte Depletion
1
2024
123
0.060
Why?
Tumor Virus Infections
1
2005
135
0.060
Why?
Antibiotic Prophylaxis
1
2005
119
0.060
Why?
Blood Transfusion
1
2006
313
0.050
Why?
Iron
1
2006
270
0.050
Why?
Retroviridae
2
2016
198
0.050
Why?
Polymerase Chain Reaction
1
2007
1586
0.050
Why?
Down Syndrome
1
2006
198
0.050
Why?
Karnofsky Performance Status
2
2015
12
0.050
Why?
Risk Assessment
3
2017
3465
0.050
Why?
North America
1
2023
241
0.050
Why?
Immunophenotyping
2
2016
329
0.050
Why?
International Cooperation
2
2014
156
0.050
Why?
Hematopoiesis
1
2005
216
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2007
511
0.050
Why?
Cost-Benefit Analysis
1
2005
510
0.050
Why?
Killer Cells, Natural
1
2005
329
0.050
Why?
Anti-Infective Agents
1
2005
265
0.050
Why?
Antilymphocyte Serum
1
2022
56
0.050
Why?
Transplant Recipients
1
2023
219
0.050
Why?
Intention to Treat Analysis
1
2021
66
0.050
Why?
T-Cell Antigen Receptor Specificity
1
2021
58
0.050
Why?
Hepatitis C
1
2005
365
0.050
Why?
Antibodies, Viral
1
2007
1153
0.040
Why?
Blast Crisis
1
2020
17
0.040
Why?
Marital Status
1
2020
33
0.040
Why?
Ifosfamide
2
2018
30
0.040
Why?
Cytogenetic Analysis
1
2020
80
0.040
Why?
In Situ Hybridization, Fluorescence
2
2016
762
0.040
Why?
Neoplasm, Residual
1
2021
122
0.040
Why?
Demography
1
2021
239
0.040
Why?
Longitudinal Studies
2
2014
1324
0.040
Why?
Imatinib Mesylate
1
2019
46
0.040
Why?
Predictive Value of Tests
1
2005
2174
0.040
Why?
Case-Control Studies
2
2019
3299
0.040
Why?
Obesity
1
2011
2248
0.040
Why?
Insurance Coverage
1
2021
122
0.040
Why?
Infant, Newborn
3
2018
8233
0.040
Why?
CD4-CD8 Ratio
1
2019
13
0.040
Why?
Fatal Outcome
2
1997
359
0.040
Why?
Feasibility Studies
2
2016
761
0.040
Why?
Liver
1
2006
1748
0.040
Why?
Medicaid
1
2021
243
0.040
Why?
Public Health
1
2020
266
0.040
Why?
Lymphocytes
1
2020
410
0.040
Why?
Retreatment
1
2018
89
0.040
Why?
Carboplatin
1
2018
76
0.040
Why?
Positron Emission Tomography Computed Tomography
1
2018
78
0.040
Why?
Proteasome Inhibitors
1
2016
60
0.030
Why?
Blood Specimen Collection
1
1997
48
0.030
Why?
Pericardial Window Techniques
1
1996
6
0.030
Why?
Probability
1
2017
320
0.030
Why?
Secondary Prevention
1
2017
218
0.030
Why?
Pericardial Effusion
1
1996
65
0.030
Why?
Mortality
1
2017
238
0.030
Why?
Body Weight
1
2020
989
0.030
Why?
Karyotype
1
2015
28
0.030
Why?
Disease Management
1
2019
528
0.030
Why?
Peripheral Nervous System Diseases
1
2016
122
0.030
Why?
Blood Cell Count
1
2015
70
0.030
Why?
Organic Chemicals
1
2015
59
0.030
Why?
Immunologic Factors
1
2016
174
0.030
Why?
Platelet Count
1
2015
136
0.030
Why?
Genes, Transgenic, Suicide
1
2015
48
0.030
Why?
Morbidity
1
2016
249
0.030
Why?
Leukocyte Count
1
2015
250
0.030
Why?
Adoptive Transfer
1
2016
236
0.030
Why?
Liver Neoplasms
1
2005
1314
0.030
Why?
Income
1
2015
135
0.030
Why?
Injections, Subcutaneous
1
2014
130
0.030
Why?
Patient Care Team
1
2018
542
0.030
Why?
Health Care Costs
1
2017
372
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2016
824
0.030
Why?
Administration, Intravenous
1
2014
143
0.030
Why?
Organ Specificity
1
2015
428
0.030
Why?
Transplantation, Isogeneic
1
2013
15
0.030
Why?
Reproducibility of Results
1
2020
2891
0.030
Why?
Ganglioneuroma
1
1993
18
0.030
Why?
Haplotypes
1
2015
522
0.030
Why?
Protein Engineering
1
2013
73
0.030
Why?
Leukocytes, Mononuclear
1
2014
326
0.030
Why?
Recovery of Function
1
2015
445
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
506
0.030
Why?
Breast Neoplasms
1
2005
2513
0.030
Why?
Spinal Cord Neoplasms
1
1993
72
0.030
Why?
Flow Cytometry
1
2015
797
0.030
Why?
Cross-Sectional Studies
1
2021
3425
0.030
Why?
Biomarkers, Tumor
1
2020
1496
0.030
Why?
Anesthesia
1
2015
207
0.020
Why?
Ultrasonography
1
1997
941
0.020
Why?
Comorbidity
1
2017
1534
0.020
Why?
Palliative Care
1
1996
433
0.020
Why?
Pain
1
2015
451
0.020
Why?
Cataract
1
2014
224
0.020
Why?
Neoplasm Grading
1
2013
272
0.020
Why?
Infertility
1
2013
78
0.020
Why?
Health Care Surveys
1
2013
285
0.020
Why?
Graft vs Tumor Effect
1
2011
7
0.020
Why?
Risk
1
2013
756
0.020
Why?
Data Collection
1
2013
381
0.020
Why?
Cell Differentiation
1
2018
1898
0.020
Why?
Adenoviridae
1
2013
606
0.020
Why?
Premedication
1
2009
42
0.020
Why?
HSP27 Heat-Shock Proteins
1
2009
8
0.020
Why?
Practice Guidelines as Topic
1
2016
1272
0.020
Why?
Drug Therapy
1
2009
87
0.020
Why?
Positron-Emission Tomography
1
2011
306
0.020
Why?
Protein Structure, Tertiary
1
2011
767
0.020
Why?
Drug Synergism
1
2009
228
0.020
Why?
Gene Expression
1
2013
1560
0.020
Why?
Lymphocyte Activation
1
2011
701
0.020
Why?
Adenocarcinoma
1
1995
1026
0.020
Why?
Enzyme Activation
1
2009
627
0.020
Why?
STAT3 Transcription Factor
1
2009
221
0.020
Why?
Tandem Repeat Sequences
1
2006
37
0.020
Why?
Immunotherapy
1
2011
680
0.020
Why?
Ribavirin
1
2005
79
0.010
Why?
Interferon-alpha
1
2005
230
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
1290
0.010
Why?
Tomography, X-Ray Computed
1
2011
2107
0.010
Why?
Surveys and Questionnaires
1
2013
3729
0.010
Why?
Immunohistochemistry
1
2006
1693
0.010
Why?
Pregnancy
1
2012
7207
0.010
Why?
Magnetic Resonance Imaging
1
2005
3573
0.010
Why?
Cisplatin
1
1993
249
0.010
Why?
KAMBLE's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (412)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_